Free Trial
NYSE:HQL

Abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis

Abrdn Life Sciences Investors logo
$12.67 -0.21 (-1.63%)
Closing price 03/31/2025 03:59 PM Eastern
Extended Trading
$12.76 +0.10 (+0.75%)
As of 03/31/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Abrdn Life Sciences Investors Stock (NYSE:HQL)

Key Stats

Today's Range
$12.37
$12.78
50-Day Range
$12.67
$14.33
52-Week Range
$12.37
$15.90
Volume
225,864 shs
Average Volume
98,729 shs
Market Capitalization
$346.54 million
P/E Ratio
N/A
Dividend Yield
11.60%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Remove Ads
Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

HQL Stock News Headlines

Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.
See More Headlines

HQL Stock Analysis - Frequently Asked Questions

Abrdn Life Sciences Investors' stock was trading at $13.12 at the beginning of 2025. Since then, HQL stock has decreased by 3.4% and is now trading at $12.67.
View the best growth stocks for 2025 here
.

Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Record date for 1/10 Dividend
11/21/2024
Ex-Dividend for 1/10 Dividend
11/21/2024
Dividend Payable
1/10/2025
Record date for 3/31 Dividend
2/21/2025
Ex-Dividend for 3/31 Dividend
2/21/2025
Today
3/31/2025
Dividend Payable
3/31/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
Investment offices, not elsewhere classified
Sub-Industry
Financial Services
Current Symbol
NYSE:HQL
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$86.69 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
24,599,000
Market Cap
$342.16 million
Optionable
Not Optionable
Beta
0.76
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSE:HQL) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners